DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Flextra-650 (Acetaminophen / Phenyltoloxamine Citrate) - Summary



Each Tablet Contains:

Acetaminophen.......... 650 mg

Citrate ............. 60 mg

Acetaminophen is a non-opiate, non-salicylate analgesic and antipyretic. Phenyltoloxamine Citrate is a antihistamine.

For the temporary relief of minor aches and pains associated with headaches, backache, muscular aches, the menstrual and premenstrual periods, colds, the flu, toothaches, as well as for minor pain from arthritis and to reduce fever.

See all Flextra-650 indications & dosage >>


Clinical Trials Related to Flextra-650 (Acetaminophen / Phenyltoloxamine)

Evaluation of the STARFlex� Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO) [Active, not recruiting]
The primary objective of the study is to determine whether the STARFlex® septal closure system will safely and effectively prevent a recurrent embolic stroke/transient ischemic attack (TIA) and mortality in patients with a PFO and to demonstrate superiority of the STARFlex® device compared to best medical therapy.

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria [Completed]
With the new reimbursement criteria, we want: To describe the average treatment duration of patients with Enbrel expressed as a number of weeks/year. To describe the number of patients who receive continuous treatment To describe the number of patients who receive intermittent treatment To describe the number of weeks off treatment

An Observational Study on the Sorin Group New Brady Leads XFine and Beflex [Completed]
This observational study is a non-interventional multi-centre, prospective study. The aim of the study is to evaluate the Sorin Group new passive- and active- fixation pacing leads. We plan to assess the acute and short term lead dislodgment rate (within the first three months following implantation) correlated with the type of lead (active- or passive- fixation). Further, we are collecting data related to leads handling and leads electrical performances

Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System [Completed]

more trials >>

Page last updated: 2001-04-16

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017